Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Bronchodilator Effects of Ipratropium or Fenoterol on Top of Tiotropium in COPD
NCT00274066Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium + Ipratropium, Tiotropium + Fenoterol and Tiotropium + Placebo (3 arms). Primary endpoint: Peak FEV1 response up to 37 days. Started Oct 2002; status: completed.
02
Drugs
ipratropium bromidefenoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00274066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274066.